Global and United States Iguratimod Market Report & Forecast 2024-2031

Report ID: 1869241 | Published Date: Jan 2025 | No. of Page: 75 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Iguratimod Product Introduction
    1.2 Global Iguratimod Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Iguratimod Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Iguratimod Sales in Volume for the Year 2017-2028
    1.3 United States Iguratimod Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Iguratimod Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Iguratimod Sales in Volume for the Year 2017-2028
    1.4 Iguratimod Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Iguratimod in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Iguratimod Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Iguratimod Market Dynamics
        1.5.1 Iguratimod Industry Trends
        1.5.2 Iguratimod Market Drivers
        1.5.3 Iguratimod Market Challenges
        1.5.4 Iguratimod Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Iguratimod Market Segment by Type
        2.1.1 14 Pcs/Box
        2.1.2 100 Pcs/Box
    2.2 Global Iguratimod Market Size by Type
        2.2.1 Global Iguratimod Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Iguratimod Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Iguratimod Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Iguratimod Market Size by Type
        2.3.1 United States Iguratimod Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Iguratimod Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Iguratimod Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Iguratimod Market Segment by Application
        3.1.1 Antirheumatic
        3.1.2 Immunoregulation
        3.1.3 Other
    3.2 Global Iguratimod Market Size by Application
        3.2.1 Global Iguratimod Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Iguratimod Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Iguratimod Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Iguratimod Market Size by Application
        3.3.1 United States Iguratimod Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Iguratimod Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Iguratimod Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Iguratimod Competitor Landscape by Company
    4.1 Global Iguratimod Market Size by Company
        4.1.1 Top Global Iguratimod Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Iguratimod Revenue by Manufacturer (2017-2022)
        4.1.3 Global Iguratimod Sales by Manufacturer (2017-2022)
        4.1.4 Global Iguratimod Price by Manufacturer (2017-2022)
    4.2 Global Iguratimod Concentration Ratio (CR)
        4.2.1 Iguratimod Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Iguratimod in 2021
        4.2.3 Global Iguratimod Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Iguratimod Manufacturing Base Distribution, Product Type
        4.3.1 Global Iguratimod Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Iguratimod Product Type
        4.3.3 Date of International Manufacturers Enter into Iguratimod Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Iguratimod Market Size by Company
        4.5.1 Top Iguratimod Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Iguratimod Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Iguratimod Sales by Players (2020, 2021 & 2022)
5 Global Iguratimod Market Size by Region
    5.1 Global Iguratimod Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Iguratimod Market Size in Volume by Region (2017-2028)
        5.2.1 Global Iguratimod Sales in Volume by Region: 2017-2022
        5.2.2 Global Iguratimod Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Iguratimod Market Size in Value by Region (2017-2028)
        5.3.1 Global Iguratimod Sales in Value by Region: 2017-2022
        5.3.2 Global Iguratimod Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Iguratimod Market Size YoY Growth 2017-2028
        6.1.2 North America Iguratimod Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Iguratimod Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Iguratimod Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Iguratimod Market Size YoY Growth 2017-2028
        6.3.2 Europe Iguratimod Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Iguratimod Market Size YoY Growth 2017-2028
        6.4.2 Latin America Iguratimod Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Iguratimod Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Iguratimod Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Simcere Pharmaceutical
        7.1.1 Simcere Pharmaceutical Corporation Information
        7.1.2 Simcere Pharmaceutical Description and Business Overview
        7.1.3 Simcere Pharmaceutical Iguratimod Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Simcere Pharmaceutical Iguratimod Products Offered
        7.1.5 Simcere Pharmaceutical Recent Development
    7.2 Toyama Chemical
        7.2.1 Toyama Chemical Corporation Information
        7.2.2 Toyama Chemical Description and Business Overview
        7.2.3 Toyama Chemical Iguratimod Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Toyama Chemical Iguratimod Products Offered
        7.2.5 Toyama Chemical Recent Development
    7.3 Eisai
        7.3.1 Eisai Corporation Information
        7.3.2 Eisai Description and Business Overview
        7.3.3 Eisai Iguratimod Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Eisai Iguratimod Products Offered
        7.3.5 Eisai Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Iguratimod Industry Chain Analysis
    8.2 Iguratimod Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Iguratimod Distributors
    8.3 Iguratimod Production Mode & Process
    8.4 Iguratimod Sales and Marketing
        8.4.1 Iguratimod Sales Channels
        8.4.2 Iguratimod Distributors
    8.5 Iguratimod Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Iguratimod CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Iguratimod Market Trends
    Table 3. Iguratimod Market Drivers
    Table 4. Iguratimod Market Challenges
    Table 5. Iguratimod Market Restraints
    Table 6. Global Iguratimod Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Iguratimod Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Iguratimod Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Iguratimod Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Iguratimod Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Iguratimod Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Iguratimod Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Iguratimod Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Iguratimod Sales Share by Manufacturer, 2017-2022
    Table 15. Global Iguratimod Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Iguratimod Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Iguratimod by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iguratimod as of 2021)
    Table 18. Top Players of Iguratimod in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Iguratimod Product Type
    Table 20. Date of International Manufacturers Enter into Iguratimod Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Iguratimod Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Iguratimod Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Iguratimod Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Iguratimod Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Iguratimod Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Iguratimod Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Iguratimod Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Iguratimod Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Iguratimod Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Iguratimod Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Iguratimod Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Iguratimod Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Iguratimod Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Iguratimod Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Iguratimod Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Iguratimod Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Iguratimod Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Iguratimod Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Iguratimod Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Iguratimod Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Simcere Pharmaceutical Corporation Information
    Table 43. Simcere Pharmaceutical Description and Business Overview
    Table 44. Simcere Pharmaceutical Iguratimod Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Simcere Pharmaceutical Iguratimod Product
    Table 46. Simcere Pharmaceutical Recent Development
    Table 47. Toyama Chemical Corporation Information
    Table 48. Toyama Chemical Description and Business Overview
    Table 49. Toyama Chemical Iguratimod Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Toyama Chemical Product
    Table 51. Toyama Chemical Recent Development
    Table 52. Eisai Corporation Information
    Table 53. Eisai Description and Business Overview
    Table 54. Eisai Iguratimod Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Eisai Product
    Table 56. Eisai Recent Development
    Table 57. Key Raw Materials Lists
    Table 58. Raw Materials Key Suppliers Lists
    Table 59. Iguratimod Customers List
    Table 60. Iguratimod Distributors List
    Table 61. Research Programs/Design for This Report
    Table 62. Key Data Information from Secondary Sources
    Table 63. Key Data Information from Primary Sources
List of Figures
    Figure 1. Iguratimod Product Picture
    Figure 2. Global Iguratimod Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Iguratimod Market Size 2017-2028 (US$ Million)
    Figure 4. Global Iguratimod Sales 2017-2028 (K Pcs)
    Figure 5. United States Iguratimod Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Iguratimod Market Size 2017-2028 (US$ Million)
    Figure 7. United States Iguratimod Sales 2017-2028 (K Pcs)
    Figure 8. United States Iguratimod Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Iguratimod Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Iguratimod Report Years Considered
    Figure 11. Product Picture of 14 Pcs/Box
    Figure 12. Product Picture of 100 Pcs/Box
    Figure 13. Global Iguratimod Market Share by Type in 2022 & 2028
    Figure 14. Global Iguratimod Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Iguratimod Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Iguratimod Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Iguratimod Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Iguratimod Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Iguratimod Market Share by Type in 2022 & 2028
    Figure 20. United States Iguratimod Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Iguratimod Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Iguratimod Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Iguratimod Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Iguratimod Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Antirheumatic
    Figure 26. Product Picture of Immunoregulation
    Figure 27. Product Picture of Other
    Figure 28. Global Iguratimod Market Share by Application in 2022 & 2028
    Figure 29. Global Iguratimod Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Iguratimod Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Iguratimod Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Iguratimod Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Iguratimod Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Iguratimod Market Share by Application in 2022 & 2028
    Figure 35. United States Iguratimod Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Iguratimod Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Iguratimod Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Iguratimod Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Iguratimod Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Iguratimod Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Iguratimod Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Iguratimod Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Iguratimod Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Iguratimod Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Iguratimod Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Iguratimod Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Iguratimod Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Iguratimod Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Iguratimod Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Iguratimod Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Iguratimod Value Chain
    Figure 74. Iguratimod Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Simcere Pharmaceutical
Toyama Chemical
Eisai
Frequently Asked Questions
Iguratimod report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Iguratimod report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Iguratimod report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Reflective Fabric

Reflective Fabric market is segmented by region (country), players, by Type and by Application. P ... Read More

Frame Scaffolding

Frame Scaffolding market is segmented by region (country), players, by Type and by Application. P ... Read More

Ruxolitinib

Ruxolitinib market is segmented by region (country), players, by Type and by Application. Players ... Read More